H2medi Co., Ltd. (CEO Kim Byung-ho), which develops high quality cosmetics for dermatology and aesthetics, has unveiled its new product ‘LHALA Doctor’. ‘LHALA Doctor’ is a peeling and skin regeneration product developed based on the ingredients of the existing product ‘LHALA Peel’, combining INCUBE platform technology, PLLA particle manufacturing technology, and QPT™ patented technology. ‘LHALA Peel’ provides skin exfoliation, protective film formation, collagen remodeling, and inflammatory substance removal functions with ingredients such as LHA, H2sol™, Lipid, and INCUBE 504. On the other hand, ‘LHALA Doctor’ has enhanced skin regeneration effects by adding INCUBE 501, INCUBE 701, QPT™, and Calcium to these ingredients. In particular, INCUBE 701 (PLLA) included in ‘LHALA Doctor’ promotes collagen synthesis, and QPT™ adds UV protection. INCUBE platform technology enables selective storage and release of ingredients, and PLLA particle manufacturing technology induces collagen production through uniform tissue stimulation. This technology was developed in collaboration between Labincube Co., Ltd., the patent holder of INCUBE and H2sol™, and H2medi Co., Ltd. This new product is expected to be used primarily in dermatology, plastic surgery, and obstetrics and gynecology. An H2Medi official stated, “LHALA Doctor is a product that comprehensively supports elements necessary for skin regeneration, such as strengthening the skin barrier, suppressing inflammation, and remodeling collagen,” and “We will continue to present new standards in the Korean glass skin K Beauty cosmetics market through research and development.” *source: https://www.dailyscanner.com/lhala-peel-headquarter-h2medi-upgraded-version-glass-skin-peeling-lhala-doctor/
H2medi Co., Ltd. (CEO Kim Byung-ho), which develops high quality cosmetics for dermatology and aesthetics, has unveiled its new product ‘LHALA Doctor’. ‘LHALA Doctor’ is a peeling and skin regeneration product developed based on the ingredients of the existing product ‘LHALA Peel’, combining INCUBE platform technology, PLLA particle manufacturing technology, and QPT™ patented technology. ‘LHALA Peel’ provides skin exfoliation, protective film formation, collagen remodeling, and inflammatory substance removal functions with ingredients such as LHA, H2sol™, Lipid, and INCUBE 504. On the other hand, ‘LHALA Doctor’ has enhanced skin regeneration effects by adding INCUBE 501, INCUBE 701, QPT™, and Calcium to these ingredients. In particular, INCUBE 701 (PLLA) included in ‘LHALA Doctor’ promotes collagen synthesis, and QPT™ adds UV protection. INCUBE platform technology enables selective storage and release of ingredients, and PLLA particle manufacturing technology induces collagen production through uniform tissue stimulation. This technology was developed in collaboration between Labincube Co., Ltd., the patent holder of INCUBE and H2sol™, and H2medi Co., Ltd. This new product is expected to be used primarily in dermatology, plastic surgery, and obstetrics and gynecology. An H2Medi official stated, “LHALA Doctor is a product that comprehensively supports elements necessary for skin regeneration, such as strengthening the skin barrier, suppressing inflammation, and remodeling collagen,” and “We will continue to present new standards in the Korean glass skin K Beauty cosmetics market through research and development.” *source: https://www.dailyscanner.com/lhala-peel-headquarter-h2medi-upgraded-version-glass-skin-peeling-lhala-doctor/